Genta up on data deluge

GNTA was up 49% on Monday after reporting data from studies of cancer compounds Genasense and Ganite. This weekend at

Read the full 207 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE